Company research
Pharming Group N.V.
CIK 1828316Updated Sep 26, 2026
SecurityPHAR · NASDAQ · adr
PHAR price & chart
Loading TradingView…
NASDAQ:PHAR on TradingView ↗In the news
Pharming Group N.V. Investigated by the Portnoy Law Firm ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | 2,538,000Source | -11,841,000Source | -10,548,000Source | 13,674,000Source |
| Additional Financial Items | ||||
| AdjustmentsForCurrentTaxOfPriorPeriodUSD | 765,000Source | -315,000Source | -241,000Source | 9,000Source |
| AdjustmentsForDeferredTaxOfPriorPeriodsUSD | -334,000Source | 1,846,000Source | 73,000Source | 124,000Source |
| AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossUSD | 11,216,000Source | 16,070,000Source | 15,925,000Source | 13,188,000Source |
| AdjustmentsForFinanceCostsUSD | 17,901,000Source | 9,887,000Source | 9,069,000Source | 5,463,000Source |
| AdjustmentsForFinanceIncomeUSD | 2,176,000Source | 6,843,000Source | 3,663,000Source | 4,485,000Source |
| AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesUSD | — | 0Source | 0Source | 12,242,000Source |
| AdjustmentsForSharebasedPaymentsUSD | 13,766,000Source | 11,248,000Source | 9,251,000Source | 6,392,000Source |
| GeneralAndAdministrativeExpenseUSD | 79,958,000Source | 70,650,000Source | 55,877,000Source | 46,016,000Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | 4,599,000Source | 15,584,000Source | 655,000Source | 1,235,000Source |
| IncreaseDecreaseInWorkingCapitalUSD | -10,385,000Source | 10,072,000Source | 16,961,000Source | 387,000Source |
| InterestPaidClassifiedAsFinancingActivitiesUSD | 5,067,000Source | 4,457,000Source | 4,046,000Source | 3,952,000Source |
| InterestReceivedClassifiedAsOperatingActivitiesUSD | 2,069,000Source | 5,201,000Source | 2,883,000Source | 85,000Source |
| OtherAdjustmentsToReconcileProfitLossUSD | 0Source | 0Source | -1,079,000Source | -1,576,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 4,245,000Source | 4,008,000Source | 5,126,000Source | 3,311,000Source |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | 0Source | 104,539,000Source | — | — |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | — | — | — | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | — |
| Total Revenue | — | — | — | — |
| Additional Financial Items | ||||
| ApplicableTaxRatenumber | 0.26Source | — | — | — |
| AverageEffectiveTaxRatenumber | 0.8Source | — | — | — |
| BasicEarningsLossPerShareUSD per share | 0Source | -0.02Source | -0.02Source | 0.02Source |
| CurrentTaxExpenseIncomeUSD | 7,692,000Source | 9,287,000Source | 5,343,000Source | 3,761,000Source |
| DepreciationRightofuseAssetsUSD | 2,973,000Source | 3,374,000Source | 3,664,000Source | 3,020,000Source |
| DilutedEarningsLossPerShareUSD per share | 0Source | -0.02Source | -0.02Source | 0.02Source |
| EmployeeBenefitsExpenseUSD | 127,359,000Source | 104,186,000Source | 92,525,000Source | 68,321,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | 13,767,000Source | 11,253,000Source | 9,251,000Source | 6,392,000Source |
| FinanceCostsUSD | 196,000Source | 56,000Source | 134,000Source | 105,000Source |
| GeneralAndAdministrativeExpenseUSD | 79,958,000Source | 70,650,000Source | 55,877,000Source | 46,016,000Source |
| GrossProfitUSD | 330,634,000Source | 261,801,000Source | 220,104,000Source | 188,060,000Source |
| ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillUSD | — | 0Source | 253,000Source | 0Source |
| IncomeTaxExpenseContinuingOperationsUSD | 10,310,000Source | 3,349,000Source | -1,464,000Source | 1,313,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 1,034,000Source | 1,038,000Source | 1,088,000Source | 622,000Source |
| OtherFinanceCostUSD | 18,140,000Source | 9,944,000Source | 9,069,000Source | 5,463,000Source |
| OtherIncomeUSD | 6,528,000Source | 2,177,000Source | 23,349,000Source | 14,523,000Source |
| PostemploymentBenefitExpenseDefinedBenefitPlansUSD | 4,582,000Source | 3,629,000Source | 2,980,000Source | 2,284,000Source |
| ProfitLossAttributableToNoncontrollingInterestsUSD | -313,000Source | — | — | — |
| ProfitLossAttributableToOwnersOfParentUSD | 2,851,000Source | — | — | — |
| ProfitLossBeforeTaxUSD | 12,847,000Source | -8,492,000Source | -12,012,000Source | 14,987,000Source |
| ProfitLossFromOperatingActivitiesUSD | 25,842,000Source | -8,621,000Source | -5,387,000Source | 18,233,000Source |
| ResearchAndDevelopmentExpenseUSD | 100,367,000Source | 83,147,000Source | 68,914,000Source | 52,531,000Source |
| ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodUSD | 623,000Source | -1,760,000Source | -289,000Source | -1,083,000Source |
| TaxRateEffectOfForeignTaxRatesnumber | -0.02Source | — | — | — |